Annual Drug Patent Expirations for ORACEA
Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ORACEA.
This drug has twenty-nine patent family members in thirteen countries.
The generic ingredient in ORACEA is doxycycline. Two suppliers are listed for this compound. Additional details are available on the doxycycline profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
